Cancer clinical trials in the region Auvergne-Rhône-Alpes
445 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Breast cancer
#NCT05800275
HER2 Positive
Metastatic
1
2
3 or more
Centre Léon Bérard (Lyon), Centre Jean Perrin (Clermont Ferrand )
UNICANCER
Phase 2
Lung cancer
#NCT04614103
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
1
2
Immunotherapy
Chemotherapy
Targeted therapy
ALK
EGFR
ROS-1
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite)
Iovance Biotherapeutics
Phase 2
Colon cancer
Rectal cancer
#NCT05310643
#2024-516313-20-00
Adenocarcinoma
Metastatic
MSI/dMMR
1
2
3 or more
Immunotherapy
Chemotherapy
Targeted therapy
MSS/pMMR
Centre Léon Bérard (Lyon)
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Phase 2
Colon cancer
Rectal cancer
#NCT04262687
Metastatic
MSS/pMMR
None
1
Systemic Treatment-Naive
Surgery
Chemotherapy
MSI/dMMR
Immunotherapy
Immunotherapy
CHU Saint-Étienne (Saint-Priest-en-Jarez), Hôpitaux Drôme Nord (Romans-sur-Isère), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand)
Fédération Francophone de Cancérologie Digestive
Phase 2
Breast cancer
#NCT05386108
#2024-512878-98-00
HER2 Negative
HR Positive
Metastatic
1
2
3 or more
Chemotherapy
Targeted therapy
Hormone therapy
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Centre Jean Perrin (Clermont Ferrand )
Stemline Therapeutics, Inc.
Phase 2
Lung cancer
#NCT06656598
#2024-517316-29-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
None
Systemic Treatment-Naive
ALK
EGFR
ROS-1
Immunotherapy
Chemotherapy
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite)
Intergroupe Francophone de Cancérologie Thoracique
Phase 2
Lymphoma
#NCT06526793
B cell lymphoma
Large B cell lymphoma
Follicular lymphoma
None
Treated / Controled
> 60 ml/min
50-60 ml/min
30-50 ml/min
2
3 or more
Systemic Treatment-Naive
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite)
AstraZeneca
Phase 2
Lung cancer
#NCT06465329
#2023-509806-31-00
NSCLC (Non-Small Cell Lung Cancer)
Localized
None
Systemic Treatment-Naive
ALK
EGFR
Radiotherapy
Centre Hospitalier Universitaire de Grenoble (La Tronche)
Regeneron Pharmaceuticals
Phase 2
Lymphoma
#NCT04728893
#2023-504931-42-00
B cell lymphoma
Mantel cell lymphoma
Follicular lymphoma
Marginal zone lymphoma
None
Treated / Controled
1
2
3 or more
Chemotherapy
Targeted therapy
Monoclonal antibodies
Systemic Treatment-Naive
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite)
Merck Sharp & Dohme LLC
Phase 2
Lung cancer
#NCT03175224
#2024-514542-37-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
MET
None
1
Targeted therapy
ALK
BRAF
KRAS G12C
KRAS non G12C
NTRK-1/2/3
RET
ROS-1
Centre Léon Bérard (Lyon)
Apollomics